| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $395.7M | — | +10.4% |
| Cost of Revenue | $77.0M | — | +19.0% |
| Gross Profit | $318.7M | — | +8.5% |
| R&D Expense | $80.3M | — | +2.0% |
| SG&A Expense | $76.9M | — | +15.2% |
| Operating Income | -$20.7M | — | -169.1% |
| Pre-tax Income | -$2.8M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.10B | +5.9% | +28.8% |
| Accounts Receivable | $32.1M | -0.7% | +0.6% |
| Current Assets | $7.33B | +1.3% | +18.1% |
| Total Assets | $10.15B | +0.9% | +12.2% |
| Current Liabilities | $4.38B | -4.6% | +8.0% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $96.9M | — | +9.3% |
| Capital Expenditures | $1.3M | — | +7541.2% |
| Investing Cash Flow | -$108.7M | — | +22.1% |
| Financing Cash Flow | $1.1M | — | +101.0% |
| Free Cash Flow | $95.6M | — | +7.9% |
| -127.6% |
| Income Tax | $149K | — | -88.2% |
| Net Income | -$3.0M | — | -133.2% |
| EPS (Basic) | -$0.03 | — | -137.5% |
| EPS (Diluted) | -$0.03 | — | -137.5% |
| $1.87B |
| +8.8% |
| +103.9% |
| Total Liabilities | $6.27B | +1.9% | +24.6% |
| Stockholders' Equity | $3.88B | -0.8% | -3.3% |